FDC LTD. - 531599 - Closure of Trading Window
Intimation of Closure of Trading Window with effect from July 01, 202425-06-2024
FDC LTD. - 531599 - Closure of Trading Window
Intimation of Closure of Trading Window with effect from July 01, 2024FDC LTD. - 531599 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, Please find enclosed copies of Newspaper Advertisement published on Thursday June 20, 2024 in Business Standard (All additions in English) and Loksatta (Marathi)(Chhatrapati Sambhajinagar) for information on completion of dispatch of Postal Ballot Notice and details on remote e-voting.FDC LTD. - 531599 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find enclosed the Postal Ballot Notice dated May 29, 2024 along with the Explanatory Statement ("Notice") for seeking approval of Shareholders for Resolution mentioned in the Notice to be passed through Special Resolution by way of remote e-voting process.FDC LTD. - 531599 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Regulation 39(3) of SEBI (LODR) Regulations 2015.FDC LTD. - 531599 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (LODR) Reg 2015, this is to inform that the following shareholders has reported to the Company / RTA about the Loss of share certificate.FDC LTD. - 531599 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of the SEBI (LODR) Regulations, we would like to inform you that the Company has issued a Duplicate Share Certificate in lieu of the Original Share Certificate reported lost/misplaced.Q4FY24 Quarterly & FY24 Annual Result Announced for FDC Ltd.
Pharmaceuticals company FDC announced Q4FY24 & FY24 results: Operating Revenue FDC Limited reported an increase in operating revenue, with a 6.3% growth in the fourth quarter (Q4FY24) and an 8.9% growth for the full fiscal year (FY24) compared to the previous corresponding periods. EBITDAs and Profitability The company's EBITDA grew significantly, with an increase of 15.1% for Q4 and 34.9% for the full year. Profit after tax (PAT) for Q4FY24 was reported at Rs 46 crore, showing a growth of 50.9%, and Rs 305 crore for FY24, marking an increase of 57.4% year-over-year. Earnings Per Share (EPS) Earnings Per Share saw a substantial rise for both Q4FY24 and FY24, increasing by 53.7% and 59.3% respectively, indicating a strong performance by the company. Business-wise Sales Breakdown Domestic formulations showed growth, particularly driven by flagship brands such as Electral, Zifi, Enerzal, and Zifi-O. US and Emerging Markets formulating businesses are also trending positively, although US formulations saw a slight decrease in the fourth quarter. API sales exhibited a significant growth of 24.0% for the fourth quarter and an 11.9% increase for the fiscal year. Geographical Revenue Contributions Revenue from international operations, specifically in the US and Rest of the World (ROW) markets, has been notable, with consolidated revenue showing a 12% increase. The export formulations accounted for 15% of the total consolidated revenue. Result PDFFDC LTD. - 531599 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached herewith the Press Release issued in relation to the Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Year ended March 31, 2024FDC LTD. - 531599 - Outcome Of Board Meeting May 29, 2024
Outcome of Board Meeting held on May 29, 2024FDC LTD. - 531599 - Board Meeting Outcome for Outcome Of Board Meeting May 29, 2024
Outcome of Board Meeting May 29, 2024